Ascendis Pharma FY 2025 Results: More Than A Takeover Story [Seeking Alpha]
Ascendis Pharma A/S - American Depositary Shares (ASND)
Last ascendis pharma a/s - american depositary shares earnings: 11/18 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ascendispharma.com
Company Research
Source: Seeking Alpha
ASND's 2025 product revenue surged to €684 million, with Yorvipath accounting for nearly 70% and operating profit turning positive in 4Q25. TransCon CNP's upcoming FDA decision is a major catalyst, but ASND now offers multiple commercial drivers, reducing binary risk. Valuation is rich at ~16.6x forward EV/sales, reflecting expectations for sustained growth, platform optionality, and eventual profitability. J Studios/DigitalVision via Getty Images Thesis Over the past couple of month we've seen Ascendis Pharma ( ASND ) shares move higher due to some speculative takeover news. Back in January, shares saw a 7.5% jump after traders again circulated fresh takeover chatter tied This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compens
Show less
Read more
Impact Snapshot
Event Time:
ASND
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ASND alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ASND alerts
High impacting Ascendis Pharma A/S - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
ASND
News
- The Boston Globe to Host Rare Disease SummitPR Newswire
- Ascendis Pharma A/S (NASDAQ:ASND) was given a new $325.00 price target on by analysts at Stifel Nicolaus.MarketBeat
- BioNJ Elects Board Officers and TrusteesPR Newswire
- Ascendis Pharma A/S (NASDAQ:ASND) had its price target raised by analysts at Wedbush from $240.00 to $273.00. They now have an "outperform" rating on the stock.MarketBeat
- Ascendis Pharma A/S (NASDAQ:ASND) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..MarketBeat
ASND
Earnings
- 2/11/26 - Miss
ASND
Sec Filings
- 2/11/26 - Form 6-K
- 2/11/26 - Form 20-F
- 2/11/26 - Form SCHEDULE
- ASND's page on the SEC website